Gambro is a Swedish-based medical technology company that develops, manufactures and supplies products and therapies for kidney and liver dialysis, myeloma kidney therapy and other extracorporeal therapies for chronic and acute patients.
The deal may be finalized within two weeks. Baxter has been negotiating with Gambro for almost a year.
Baxter International is headquartered in Deerfield, Ill.
Related Articles on Company Acquisitions:
Alcon Acquires Ophthalmic Division of Sensomotoric Instruments
Wright Medical to Acquire BioMimetic Therapeutics
Allergan to Acquire SkinMedica
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
